glp-1 and hashimotos : r/Hashimotos Resmetirom and GLP-1 agonists for

If clinically effective, this modality could lower treatment barriers associated with injectable insulin and delay progression to advanced disease stages

doi: 10.3389/fphar.2026.1791206 Received 19 January 2026 Revised 13 April 2026 Accepted 14 April 2026 Published 01 May 2026 Volume 17 - 2026 Edited by Kabirullah Lutfy, Western University of Health Sciences, United States Reviewed by Marsida Kallupi, University of California, San Diego, United States Christina Merritt, University of Texas Medical Branch at Galveston, United States Updates Copyright 2026 Hrickova, Demirci, Amchova and Ruda-Kucerova

During perimenopause, your levels of estrogen and progesterone begin to naturally decline

Both are GLP-1 medications for weight management, but they work slightly differently

& Nemmani, K